Filgrastims sikkerhed og effekt efter administration til patienter med myelodysplastisk syndrom eller kronisk myeloid leukæmi er ikke fastlagt.
The safety and efficacy of filgrastim administration in patients with myelodysplastic syndrome or chronic myelogenous leukaemia have not been established.